Article
Direct-to-consumer genetic testing: failure is not an option.
Clinical pharmacology and therapeutics - 1 Jul 2009
Altman R B
Abstract excerpt
Direct-to-consumer genetic testing is an unavoidable consequence of our ability to cheaply and accurately measure the genome. Some are troubled by the loss of control over how and when this information is disclosed to individuals, but it is difficult to imagine any way to prevent the wide availability of these data. Therefore, the key challenge is to set up social, educational, and technical means to support...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
